A pivotal registration study of Epitinib in subjects with non-small cell lung cancer with brain metastasis.

Trial Profile

A pivotal registration study of Epitinib in subjects with non-small cell lung cancer with brain metastasis.

Planning
Phase of Trial: Phase III

Latest Information Update: 31 Jul 2017

At a glance

  • Drugs Epitinib (Primary)
  • Indications Brain metastases; Non-small cell lung cancer
  • Focus Therapeutic Use
  • Most Recent Events

    • 31 Jul 2017 According to Chi-Med media release, company plans to initiate Phase III registration study in China in late 2017 or early 2018
    • 29 Aug 2016 New trial record
    • 02 Aug 2016 According to Chi-Med media release, company targets to initiate pivotal registration study in H1 2017.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top